Original Research
Accepted on 27 Feb 2026
Impact of HER2 Immunohistochemistry Score on Pathological Complete Response and Survival in HER2-Positive Breast Cancer Treated with Neoadjuvant Therapy: Differential Outcomes by Hormone Receptor Status
in Breast Cancer